Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Obesity × Propofol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Lung Neoplasms 5 Neoplasms 4 Colonic Neoplasms 3 Prostatic Neoplasms 2 Patient Satisfaction 2 Ovarian Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Tuberculosis, Pulmonary 1 Thoracic Diseases 1 Supratentorial Neoplasms 1 Stomach Ulcer 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Polyps 1 Pituitary Neoplasms 1 Pain, Postoperative 1 Pain 1 Overweight 1 Obesity 1 Neurofibromatoses 1 Neoplastic Cells, Circulating 1 Mouth Neoplasms 1 Melanoma 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hypoxia 1 Hydrocephalus 1 Headache 1 Fractures, Bone 1

Interventions

Metformin 6 Exercise 3 Liraglutide 2 Docosahexaenoic Acids 2 Diet 2 sibutramine 1 semaglutide 1 Ursodeoxycholic Acid 1 Topiramate 1 Tirzepatide 1 Propofol 1 Nutrition Therapy 1 Nutrition Assessment 1 Exenatide 1 Doxorubicin 1 Cyclophosphamide 1 Caloric Restriction 1 (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05518929 2024-06-07

SpO2

RenJi Hospital

Phase 4 Completed

GastrointestinalOther

Obesity, Stomach Neoplasms, Stomach Ulcer, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡